Dr. Halis Kaan Akturk (@drhkakturk) 's Twitter Profile
Dr. Halis Kaan Akturk

@drhkakturk

Rising Star Awardee @theaace Scientific Sessions Committee DiabetesTechnology Chair @amdiabetesassn Assoc Prof @barbaradavisctr Alumni @mayoclinic @istanbultipf

ID: 1347721747903164420

calendar_today09-01-2021 01:48:32

755 Tweet

1,1K Followers

652 Following

Dr. Halis Kaan Akturk (@drhkakturk) 's Twitter Profile Photo

Dr. Zaharieva Dessi Zaharieva is talking on how to manage exercise in different AID systems in people with type 1 diabetes at the EPIC patient conference for diabetes. #EPIC2025 #EpiConf2025 Thanks for coming Dessi Zaharieva and it was a great talk.

Dr. Zaharieva <a href="/5Dess/">Dessi Zaharieva</a> is talking on how to manage exercise in different AID systems in people with type 1 diabetes at the EPIC patient conference for diabetes. #EPIC2025 #EpiConf2025 
Thanks for coming <a href="/5Dess/">Dessi Zaharieva</a> and it was a great talk.
Dr. Halis Kaan Akturk (@drhkakturk) 's Twitter Profile Photo

I and Viral Shah are happy to announce that our pocket book "Clinical Decision Algorithms in Diabetes" is going to be launched at the #ADA2025 in Chicago from American Diabetes Association Press. We spent almost a year and converted entire ADA Standards of Care into flow charts.

I and Viral Shah are happy to announce that our pocket book "Clinical Decision Algorithms in Diabetes" is going to be launched at the #ADA2025 in Chicago from American Diabetes Association Press.
We spent almost a year and converted entire ADA Standards of Care into flow charts.
Dr. Halis Kaan Akturk (@drhkakturk) 's Twitter Profile Photo

Insulet’s Omnipod 5 App for iPhone with Dexcom G7 Integration Now Available to all U.S. Users - Life Science Report lifesciencereport.com/news/nasdaq/po…

Dr. Halis Kaan Akturk (@drhkakturk) 's Twitter Profile Photo

TING (70-140 mg/dL) and TIR (70-180 mg/dL) are greater indicators for diabetic complications at #ADA2025 by Tadej Battelino Time to retire HbA1c and use CGM metrics for follow up.

TING (70-140 mg/dL) and TIR (70-180 mg/dL) are greater indicators for diabetic complications at #ADA2025 by <a href="/TBattelino/">Tadej Battelino</a> 
Time to retire HbA1c and use CGM metrics for follow up.
Endocrine Today (@endocrinetoday) 's Twitter Profile Photo

Halls Kaan Akturk, MD, prepares the #ADA2025 audience for the presentation of the ADJUST-T1D trial of semaglutide 1 mg on top of auto insulin delivery in patients with T1D. Stay tuned for more! #ADASciSessions

Halls Kaan Akturk, MD, prepares the #ADA2025 audience for the presentation of the ADJUST-T1D trial of semaglutide 1 mg on top of auto insulin delivery in patients with T1D. 

Stay tuned for more!

#ADASciSessions
Dr. Halis Kaan Akturk (@drhkakturk) 's Twitter Profile Photo

We reported the first long term double blind study of Semaglutide in type 1 diabetes. Semaglutide is effective in reducing weight, insulin dose and HbA1c in type 1 diabetes.

diaTribe (@diatribenews) 's Twitter Profile Photo

.Tandem Diabetes Care' t:slim X2 Now Compatible With FreeStyle Libre 3 Plus Tandem recently announced that its t:slim X2 insulin pump with Control-IQ+ AID technology now works with Abbott' FreeStyle Libre 3 Plus CGM sensor in the U.S.

Dr. Halis Kaan Akturk (@drhkakturk) 's Twitter Profile Photo

My first book with Dr. Shah is published from American Diabetes Association. It will be a great pocket reference for clinicians taking care of people with diabetes. American Diabetes Association - DiabetesPro You can purchase from shopdiabetes.org/collections/pr…

My first book with Dr. Shah is published from American Diabetes Association. It will be a great pocket reference for clinicians taking care of people with diabetes. 

<a href="/ADA_DiabetesPro/">American Diabetes Association - DiabetesPro</a> 
You can purchase from shopdiabetes.org/collections/pr…
Dr. Halis Kaan Akturk (@drhkakturk) 's Twitter Profile Photo

Read our recent study on cannabis use in type 1 diabetes and it is commonly misdiagnosed as gastroparesis and how to differentiate cannabis related symptoms vs gastroparesis in people with type 1 diabetes.

Dr. Halis Kaan Akturk (@drhkakturk) 's Twitter Profile Photo

Dr. DeFronzo summarized the benefits of GLP-1 analogs. #ATDC2025 Drs. Phillip and Sherr are chairing. GLP-1 and SGLT-2 are mainstay in diabetes management unless otherwise indicated.

Dr. DeFronzo summarized the benefits of GLP-1 analogs. #ATDC2025 
Drs. Phillip and Sherr are chairing. GLP-1 and SGLT-2 are mainstay in diabetes management unless otherwise indicated.
Dr. Halis Kaan Akturk (@drhkakturk) 's Twitter Profile Photo

This will be the new CGM to use with 780G pump. It has features of Libre 3 Plus in many ways and made by Abbott. Other CGM made by Medtronic is Simplera and it should be on the way too. Coming soon.

Scott Isaacs (@scottisaacsmd) 's Twitter Profile Photo

Breaking! The FDA has approved Wegovy #semaglutide to treat #MASH in adults with moderate-to-advanced fibrosis. fda.gov/drugs/news-eve…

Breaking! The FDA has approved Wegovy #semaglutide to treat #MASH in adults with moderate-to-advanced fibrosis.
fda.gov/drugs/news-eve…